Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Efficacy and safety of edifoligide.

Parolari A, Alamanni F, Tremoli E, Biglioli P.

JAMA. 2006 Apr 5;295(13):1513; author reply 1514-5. No abstract available.

PMID:
16595751
2.

Efficacy and safety of edifoligide.

Desai ND, Fremes SE.

JAMA. 2006 Apr 5;295(13):1514; author reply 1514-5. No abstract available.

PMID:
16595752
3.

Efficacy and safety of edifoligide.

Lau GT, Kritharides L.

JAMA. 2006 Apr 5;295(13):1513-4; author reply 1514-5. No abstract available.

PMID:
16595750
4.

Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.

Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB Jr, Lorenz TJ, Goyal A, Gibson M, Mack MJ, Gennevois D, Califf RM, Kouchoukos NT; PREVENT IV Investigators.

JAMA. 2005 Nov 16;294(19):2446-54.

PMID:
16287955
5.

Gene therapy and vein graft patency in coronary artery bypass graft surgery.

Conti VR, Hunter GC.

JAMA. 2005 Nov 16;294(19):2495-7. No abstract available.

PMID:
16287962
6.

Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery.

Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, Namini H, Hamdan AD, Roddy SP, Belkin M, Berceli SA, DeMasi RJ, Samson RH, Berman SS; PREVENT III Investigators.

J Vasc Surg. 2006 Apr;43(4):742-751; discussion 751.

7.

Antithrombotic therapy in the coronary vein graft patient.

Israel DH, Adams PC, Stein B, Chesebro JH, Fuster V.

Clin Cardiol. 1991 Apr;14(4):283-95. Review.

8.

Tranexamic acid and early saphenous vein graft patency in conventional coronary artery bypass graft surgery: a prospective randomized controlled clinical trial.

Karski J, Djaiani G, Carroll J, Iwanochko M, Seneviratne P, Liu P, Kucharczyk W, Fedorko L, David T, Cheng D.

J Thorac Cardiovasc Surg. 2005 Aug;130(2):309-14.

9.

Augmentation of coronary bypass graft flow induced by dipyridamole and its relation to bypass graft patency.

Suma H, Takeuchi A, Sasaki S, Asada K, Suwa M, Hirota Y.

Jpn J Surg. 1988 Mar;18(2):172-8.

PMID:
3260634
10.

Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure.

Conte MS, Lorenz TJ, Bandyk DF, Clowes AW, Moneta GL, Seely BL.

Vasc Endovascular Surg. 2005 Jan-Feb;39(1):15-23.

11.

The biology of saphenous vein graft occlusion: etiology and strategies for prevention.

Bryan AJ, Angelini GD.

Curr Opin Cardiol. 1994 Nov;9(6):641-9. Review.

PMID:
7819622
12.

Meta-analysis of effect of single versus dual antiplatelet therapy on early patency of bypass conduits after coronary artery bypass grafting.

Nocerino AG, Achenbach S, Taylor AJ.

Am J Cardiol. 2013 Nov 15;112(10):1576-9. doi: 10.1016/j.amjcard.2013.07.017. Epub 2013 Sep 13. Review.

PMID:
24035160
13.

Edifoligide: a transcription factor decoy to modulate smooth muscle cell proliferation in vein bypass.

Hoel AW, Conte MS.

Cardiovasc Drug Rev. 2007 Fall;25(3):221-34. Review.

PMID:
17919257
14.

Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.

Gao G, Zheng Z, Pi Y, Lu B, Lu J, Hu S.

J Am Coll Cardiol. 2010 Nov 9;56(20):1639-43. doi: 10.1016/j.jacc.2010.03.104.

15.
16.

Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial.

Kulik A, Voisine P, Mathieu P, Masters RG, Mesana TG, Le May MR, Ruel M.

Ann Thorac Surg. 2011 Oct;92(4):1284-90; discussion 1290-1. doi: 10.1016/j.athoracsur.2011.04.107.

PMID:
21958773
17.

Long-term vein graft patency.

Bourassa MG.

Curr Opin Cardiol. 1994 Nov;9(6):685-91. Review.

PMID:
7819628
18.

Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts.

Stein PD, Dalen JE, Goldman S, Théroux P.

Chest. 1998 Nov;114(5 Suppl):658S-665S.

PMID:
9822069
19.

Radial artery graft patency relates to gender, diabetes mellitus and angiotensin inhibition.

Bartnes K, Hermansen SE, Dahl-Eriksen O, Iqbal A, Mannsverk JT, Steigen TK, Trovik T, Busund R, Dahl PE, Sørlie DG, Myrmel T.

Scand Cardiovasc J. 2010 Aug;44(4):230-6. doi: 10.3109/14017431003699810.

PMID:
20331352
20.

Comparison of graft patency, limb salvage, and antithrombotic therapy between prosthetic and autogenous below-knee bypass for critical limb ischemia.

Suckow BD, Kraiss LW, Stone DH, Schanzer A, Bertges DJ, Baril DT, Cronenwett JL, Goodney PP; Vascular Study Group of New England.

Ann Vasc Surg. 2013 Nov;27(8):1134-45. doi: 10.1016/j.avsg.2013.01.019. Epub 2013 Sep 5.

Supplemental Content

Support Center